Abstract
The role of cytology in cervical cancer screening is rapidly evolving. Widespread implementation of The Bethesda System with its accompanying atlas has provided uniform terminology and criteria for reporting cervical pathology. The development of new methods for preparing cytologic specimens as well as many other screening techniques suggests that current practices may be modified in the near future. The implementation of these new approaches may permit more conservative management of women with self- limited lesions related to HPV exposures, improve detection of serious cancer precursors, and provide more cost-effective cervical cancer screening.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 641-655 |
| Number of pages | 15 |
| Journal | Obstetrics and Gynecology Clinics of North America |
| Volume | 23 |
| Issue number | 3 |
| State | Published - 1996 |
ASJC Scopus subject areas
- Obstetrics and Gynecology